Format

Send to

Choose Destination
Am J Med. 2017 May;130(5):601.e9-601.e15. doi: 10.1016/j.amjmed.2016.12.010. Epub 2017 Jan 5.

Risk Factors for 30-Day Readmission in Adults with Sickle Cell Disease.

Author information

1
College of Medicine MD Program, Drexel University, Philadelphia, Pa.
2
Rodeghier Consultants, Chicago, Ill.
3
Department of Pediatrics and Medicine, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University School of Medicine, Nashville, Tenn.
4
Department of Pediatrics and Medicine, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University School of Medicine, Nashville, Tenn. Electronic address: adetola.kassim@vanderbilt.edu.

Abstract

BACKGROUND:

Readmission to the hospital within 30 days is a measure of quality care; however, only few modifiable risk factors for 30-day readmission in adults with sickle cell disease are known.

METHODS:

We performed a retrospective review of the medical records of adults with sickle cell disease at a tertiary care center, to identify potentially modifiable risk factors for 30-day readmission due to vasoocclusive pain episodes. A total of 88 patients ≥18 years of age were followed for 3.5 years between 2010 and 2013, for 158 first admissions for vasoocclusive pain episodes. Of these, those subsequently readmitted (cases) or not readmitted (controls) within 30 days of their index admissions were identified. Seven risk factors were included in a multivariable model to predict readmission: age, sex, hemoglobin phenotype, median oxygen saturation level, listing of primary care provider, type of health insurance, and number of hospitalized vasoocclusive pain episodes in the prior year.

RESULTS:

Mean age at admission was 31.7 (18-59) years; median time to readmission was 11 days (interquartile range 20 days). Absence of a primary care provider listed in the electronic medical record (odds ratio 0.38; 95% confidence interval, 0.16-0.91; P = .030) and the number of vasoocclusive pain episodes requiring hospitalization in the prior year were significant risk factors for 30-day readmission (odds ratio 1.30; 95% confidence interval, 1.16-1.44; P <.001).

CONCLUSION:

Improved discharge planning and ensuring access to a primary care provider may decrease the 30-day readmission rate in adults with sickle cell disease.

KEYWORDS:

30-Day readmission; Sickle cell disease; Vasoocclusive pain

PMID:
28065771
DOI:
10.1016/j.amjmed.2016.12.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center